bluebird bio, Inc.
Company Name: bluebird bio, Inc. bluebird bio, Inc. is a clinical-stage biotechnology company. The company is engaged in developing gene therapies for severe genetic and rare diseases. The company’s pipeline includes treatment candidates for childhood cerebral adrenoleukodystrophy (CCALD), beta-thalassemia major and severe sickle cell disease. The company also develops T cell-based cancer immunotherapies. Ticker Symbol: … Read more